deltatrials
Completed OBSERVATIONAL NCT00638794

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents (ADAPT-DES)

Sponsor: Cardiovascular Research Foundation, New York

Conditions Coronary Artery Disease
Interventions Drug -Eluting Stent (Taxus™, Cypher®, Endeavor™, Xience V™)
Updated 7 times since 2017 Last updated: Jan 22, 2013 Started: Jan 31, 2008 Primary completion: Dec 31, 2011 Completion: Jan 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Cardiovascular Research Foundation, New York and has accumulated 7 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Apr 2018 · 14 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 2 earlier versions

  1. Feb 2017 — Apr 2018 [monthly]

    Completed NA

  2. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cardiovascular Research Foundation, New York
  • Dickson Advanced Analytics Group
Data source: Cardiovascular Research Foundation, New York

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations